Something clarified for me in the Q&A was that the P2 trial isn't going to "double" as a registration study; they are hoping to run P2 and RS "in parallel. That implies they will have separate cohorts of patients.
PTX Price at posting:
6.7¢ Sentiment: Hold Disclosure: Held
